Kan is the Louis K. Diamond Professor of Hematology at UCSF. He was the first to establish that a single DNA mutation could result in a human disease. He monstrated this in sickle cell anemia and thalassemia, and was the first to diagnose a human disease using DNA. He discovered DNA polymorphism, which is now extensively used for genetic analysis.

The Lifetime Achievement Award from the Society of Chinese Bioscientists in America (SCBA) was presented to Kan during the group’s 11th International Symposium, held this week in San Francisco. The professional society aims to promote bioscience research and medical knowledge and promote international cooperation.

A recipient of many high honors, Kan received the prestigious Shaw Prize in Life Science and Medicine in 2004, an international award given by the Shaw Prize Foundation based in Hong Kong that recognizes breakthroughs in scientific research resulting in “a positive and profound impact on mankind.” He was honored in 1991 with the distinguished Albert Lasker Clinical Medical Research Award, the nation’s most prestigious honor in the clinical research field.

Kan is a member of the National Academy of Sciences. His research is currently focused on the use of gene therapy to treat sickle cell anemia and thalassemia. His aim is to develop cell therapy on patientspecific embryonic stem cell lines, transplanting the treated cells into patients to treat their disease. His team is carrying out research in a mouse model of sickle cell anemia in which animals have been genetically engineered to harbor a human gene that causes the disease.

Kan’s honors also include the Helmut Horten Research Award in 1995, the American College of Physicians Award in 1988, the Waterford Award in Biomedical Sciences in 1987, the Allan Award of the American Society of Human Genetics and the Gairdner International Award in 1984, and the Dameshek Award from the American Society of Hematology in 1979.

He currently serves on the Committee on Human Rights and the Executive Council of the National Academy of Sciences. He is a fellow of the Royal Society (London), a member of the Academia Sinica of Taiwan, and a foreign member of the Chinese Academy of Sciences, Beijing.

He has served as president of the American Society of Hematology and was a member of the President’s Committee on the National Medal of Science.

Born in Hong Kong, Kan graduated from the University of Hong Kong Medical School in 1958. He received clinical training in Hong Kong and the U.S. In 1970, he joined the faculty of Harvard Medical School, and in 1972, he joined the UCSF faculty. He received a D.Sc. from the University of Hong Kong in 1980 and is the recipient of several honorary degrees.